Dr. Yazmin Odia, MD, MS, FAAN

Clinical Trials

• Trial of Combination TTF(Optune), Nivolumab Plus/Minus Ipilimumab for Bevacizumab-naïve, Recurrent Glioblastoma
• Oral ONC201 in Adult Recurrent Glioblastoma and H3 K27M-mutant Glioma

Media Releases

Get to know Neuro-Oncologist Dr. Yazmin Odia, who serves patients in Miami, Florida.

Dr. Odia is the Chief of Neuro-Oncology at Miami Cancer Institute (MCI) part of Baptist Health South Florida. She also serves on the Scientific Review Committee at MCI and the Medical Executive Committee at Baptist Hospital.

She further rounds out the Institute’s highly specialized and comprehensive brain tumor program, providing the southern two-thirds of the state, Latin America, and the Caribbean access to expert neuro-oncology care. She also collaborates with clinical experts across the organization to provide treatment to patients with malignant and benign tumors of the nervous system, including primary and metastatic brain and spine cancers. She conducts local, regional, and national clinical trials that hopefully bring significant advances in neuro-oncology cancer care to patients in South Florida, the Caribbean, and beyond.

Prior to joining Miami Cancer Institute, she was an assistant professor of neurology at Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Hospital. 

A Chicago Honor Scholar, Dr. Odia received her Bachelor of Arts degree and medical degree from the University of Chicago. She received a Master of Science degree in Clinical Research at Mayo Clinic in Rochester, Minnesota. She then completed an internship in internal medicine at Johns Hopkins Bayview Medical Center, a residency in neurology at Johns Hopkins Hospital, and a clinical and research fellowship in the Neuro-Oncology Branch of the National Institutes of Health in Bethesda, Maryland.

An expert in her field, the doctor is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the professions of psychiatry and neurology. She is also board-certified in neuro-oncology by the United Council for Neurologic Subspecialties (UCNS). The UCNS is a not-for-profit corporation that formally recognizes emerging neurologic subspecialties.

A Fellow of the American Academy of Neurology (FAAN), Dr. Odia serves as Chair of the Diversity Leadership Subcommittee and member of the Leadership Development Committee, Health Care Disparities Task Force, Spanish Language Work Group, and Undergraduate Education Subcommittee. She is also a member of the American Society of Clinical Oncology and Society for Neuro-Oncology. 

Her honors include Columbia University/New York Presbyterian Hospital’s Stephen Q. Shafer Award for Humanism in Neurology and John Hopkins’ Guy M. McKhann Award for Teaching and Communication Excellence. She also received the Top Doctor Awards in New York City (2015-2016) and Miami (2018-2021) and was named a US Castle Connolly Top Doctor (2019).

Neuro-oncology is the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. Among the malignant brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-grade astrocytoma are among the worst. Neuro-oncologists are neurologists who specialize in diagnosing and treating brain and nervous system cancers and administering chemotherapy to patients.

On a more personal note, Dr. Odia speaks both English and Spanish.

Recommended Articles

• The Very Real and Deep Depression That Is Often Associated With Multiple Sclerosis

  To date, what exactly triggers the onset of MS remains unknown. In some individuals, attacks of neurologic symptoms come and go, while in others, the attacks never get better. Nevertheless, in all individuals with MS, damage to the nerves can make it difficult for the nerve impulses to travel...

• Understanding the Relationship Between Constipation and Parkinson’s

  As technology progresses, understanding about the intensive dialogue between the gut and the brain is also getting better. It is now understood that if things go wrong with this exchange, it is terrible for both of them. Changes in the activity of the gut may worsen the functioning of the brain,...

• Dealing with Anxiety and MS

  In relation to MS, anxiety can present itself, owing to the fear of the effects of MS as it progresses, and the challenges, losses, or adjustments that may be necessary as a result of MS. This fear usually comes as a threat to your sense of normal self. A sense of self refers to how you feel about...

• His Need for Speed Keeps Scott Roehm From Giving into Parkinson’s Disease

  Scott Rohm has a unique therapy for his Parkinson’s Disease symptoms. His legs tremble, but this 56-year-old Millcreek Township gentleman doesn’t let his Parkinson’s disease get him down. He still drives his Corvette up to 168 miles an hour, racing a Mustang on the road. ...

• What is a Lobotomist?

  A lobotomist is the type of specialist who performs lobotomy procedures. A lobotomy is a form of psychosurgery that was popular from the late 1930s to the early 1950s, and it was meant to treat various psychological defects.Why would you need a lobotomist?A lobotomist was required to perform...

• What to Do If a Child Has a Febrile Seizure?

  Febrile SeizureA febrile seizure usually occurs when your child has a fever or high body temperature. It can also happen without brain inflammation or certain metabolic disorders. Even though febrile seizures occur with fever, you may not notice an increase in your child’s body temperature until...